$15M for Salient Surgical

Salient Surgical Technologies of Portsmouth, NH, has raised $15 million in equity-based financing from a group of 10 unnamed investors, according to a regulatory filing published online yesterday. Established in 1999 and formerly known as Tissuelink Medical, Salient makes devices that stop bleeding and seal wounds by allowing surgeons to apply focused radio-frequency energy and saline solution to collagen fibers in the body. Salient raised $17.9 million in Series F funding in October 2008, with backing from, Piper Jafray Ventures, Arnerich Messina & Associates, Medtronic, and Rivervest Venture Partners; the Series F round came shortly after Salient withdrew plans for an $86 million initial public offering.

Wade Roush is Xconomy’s chief correspondent. You can e-mail him at, call him at (617) 252-7323, or follow him on Twitter at


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button